Germline Genetic Testing for Women With Breast Cancer: Shifting the Paradigm From Whom to Test to Whom NOT to Test
Author:
Affiliation:
1. Beth Israel Deaconess Medical Center, Boston, MA
2. Harvard Medical School, Boston, MA
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.01761
Reference23 articles.
1. A Population-Based Study of Genes Previously Implicated in Breast Cancer
2. Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
3. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
4. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
5. Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Psychological distress following multi‐gene panel testing for hereditary breast and ovarian cancer risk;Journal of Genetic Counseling;2024-07-23
2. Universal genetic counseling in breast cancer patients significantly improves overall testing rates and improves completion rates in subpopulations;Breast Cancer Research and Treatment;2024-06-01
3. Targeted genotyping for recurring variants in cancer susceptibility genes in non‐Ashkenazi Jewish patients with breast cancer diagnosed ≥50 years;Cancer;2024-04-17
4. Gynecologic Care of Black Breast Cancer Survivors;Current Breast Cancer Reports;2024-02-19
5. Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline;Journal of Clinical Oncology;2024-02-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3